Abstract
Empirical evidence suggests fishes meet the criteria for experiencing pain beyond a reasonable doubt and zebrafish are being increasingly used in studies of pain and nociception. Zebrafish are adopted across a wide range of experimental fields and their use is growing particularly in biomedical studies. Many laboratory procedures in zebrafish involve tissue damage and this may give rise to pain. Therefore, this FELASA Working Group reviewed the evidence for pain in zebrafish, the indicators used to assess pain and the impact of a range of drugs with pain-relieving properties. We report that there are several behavioural indicators that can be used to determine pain, including reduced activity, space use and distance travelled. Pain-relieving drugs prevent these responses, and we highlight the dose and administration route. To minimise or avoid pain, several refinements are suggested for common laboratory procedures. Finally, practical suggestions are made for the management and alleviation of pain in laboratory zebrafish, including recommendations for analgesia. Pain management is an important refinement in experimental animal use and so our report has the potential to improve zebrafish welfare during and after invasive procedures in laboratories across the globe.
Original language | English |
---|---|
Pages (from-to) | 261-276 |
Number of pages | 16 |
Journal | Laboratory Animals |
Volume | 58 |
Issue number | 3 |
Early online date | 5 Dec 2023 |
DOIs | |
State | Published - Jun 2024 |
Bibliographical note
Publisher Copyright:© The Author(s) 2023.
Funding
We are grateful to Carole Wilson (University College London, UK) for initial advice prior to writing the report and to FELASA for funding meetings of the working group. We thank a large number of anonymous reviewers who provided comments on the first draft of this report.
Keywords
- Anaesthesia
- analgesia
- ethics and welfare
- fish
- laboratory animal welfare
- organisms and models
- pain measurement